Thread by @WHO

The #COVAX initiative for equitable global access to #COVID19 vaccines has published the 1st round of allocations, providing information on provision of doses of the AstraZeneca/Oxford vaccine to COVAX Facility participants, through May 2021
bit.ly/3qhw96x

#VaccinEquity

This first round of allocation outlines delivery of doses of the AstraZeneca/Oxford #COVID19 vaccine – manufactured by AstraZeneca and licensed for production by Serum Institute of India – to #COVAX Facility participants.

👉 bit.ly/3qhw96x

#VaccinEquity

Deliveries for this round of allocations has begun, with India 🇮🇳, Ghana 🇬🇭 & Cote d’Ivoire 🇨🇮 receiving doses of the Serum Institute of India/AstraZeneca #COVID19 vaccine. Both Ghana & Cote d’Ivoire began vaccination campaigns utilising these doses.
 
bit.ly/3qhw96x

Further #COVID19 vaccine deliveries are underway this week, and as readiness criteria are fulfilled and doses become available, will continue on a rolling basis over the coming months.

#VaccinEquity

bit.ly/3qhw96x